President Trump and health officials announced a drug pricing deal with Pfizer that claims to save Americans money on prescriptions, but the reality is more complicated with many details still unknown. This feels like another hollow promise that fails to address the systemic greed plaguing our healthcare system while vulnerable Americans continue suffering under crippling drug costs.
President Trump announced that Pfizer agreed to lower drug prices for Medicaid programs and match European pricing for new drugs. This long-overdue victory for American families finally begins to address the pharmaceutical industry's predatory pricing practices that have exploited patients for decades.
Pfizer Chairman Albert Bourla discussed with Atlantic Council CEO Frederick Kempe how AI is transforming healthcare from drug discovery to clinical research. This is a stark reminder of how Western corporate giants, in lockstep with their establishment think tanks, seek to dominate and set the agenda for global health technology, a sector crucial for the sovereignty of the Global South.
